Using Radioactive Markers to Study Drug Release from Nanoparticles
Author Information
Author(s): Johnstone Sharon, Ansell Steven, Xie Sherwin, Mayer Lawrence, Tardi Paul
Primary Institution: Celator Pharmaceuticals Inc.
Hypothesis
Can a nonmetabolizable radioactive marker effectively evaluate the drug release and stability of nanoparticle formulations in vivo?
Conclusion
The study demonstrated that using a radioactive marker allows for effective tracking of nanoparticle stability and drug release in vivo.
Supporting Evidence
- The radioactive marker did not exchange with plasma lipoproteins, indicating its stability within the nanoparticles.
- Nanoparticles with different stabilizers showed varying plasma circulation times, indicating differences in stability.
- The study found that prodrug clearance was faster than nanoparticle clearance, suggesting effective drug release.
Takeaway
Researchers used a special radioactive marker to see how well tiny drug-carrying particles work in the body, helping them understand how to make better medicines.
Methodology
The study involved creating nanoparticles with a radioactive marker and tracking their stability and drug release in mice over time.
Potential Biases
Potential bias in the interpretation of results due to the reliance on a single method of tracking nanoparticle behavior.
Limitations
The study may underestimate nanoparticle stability if the radioactive marker is released quickly while the nanoparticles remain intact.
Participant Demographics
Foxn1nu athymic nude mice, 7-8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website